ANAGENICS LIMITED - Announcements

Market Cap $3.691M Add to my watchlist

Consumer Defensive Household & Personal Products

Anagenics Limited is an Australia-based health and beauty-tech company. The Company... Anagenics Limited is an Australia-based health and beauty-tech company. The Company offers a range of clinically validated anti-ageing and wellness products developed in-house or sourced from premium international brands. The Company, through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures and markets anti-aging products globally, with its FGF5 inhibitor hair health and hair growth products sold worldwide. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju and Lexilis brands, is sold in Japan, the United States of America and Australia. The Company’s subsidiary is BLC Cosmetics Pty Limited, which is the distributor of international and local skin care and wellbeing brands. More

Announcements

Filter Results

All Price Sensitive Only

AN1	CDY Engages Advisers to Facilitate Divestment from Lyramid		10/09/20	71.18KB	Share
AN1	FY20 Results Presentation		27/08/20	1.82MB	Share
AN1	FY20 Financial Results	PRICE SENSITIVE	27/08/20	73.95KB	Share
AN1	Appendix 4E and FY20 Financial Report	PRICE SENSITIVE	27/08/20	1.34MB	Share
AN1	CDY Signs Agreement With Premium Salon Distributor in USA	PRICE SENSITIVE	28/07/20	75.8KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	22/07/20	391.46KB	Share
AN1	Response to ASX Aware Query	PRICE SENSITIVE	09/07/20	218.16KB	Share
AN1	Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory	PRICE SENSITIVE	09/07/20	102.44KB	Share
AN1	Trading Halt	PRICE SENSITIVE	07/07/20	189.6KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	07/07/20	113.64KB	Share
AN1	Extension Of Wondfo Rapid Test Distribution Agreement	PRICE SENSITIVE	02/07/20	84.81KB	Share
AN1	Change of Director's Interest Notice - Halasz		23/06/20	245.13KB	Share
AN1	Change in substantial holding		18/06/20	652.23KB	Share
AN1	Change of Director's Interest Notice - Eck		18/06/20	158.59KB	Share
AN1	Change of Director's Interest Notice - Halasz		18/06/20	207.02KB	Share
AN1	Appendix 3G		18/06/20	277.59KB	Share
AN1	Appendix 2A		18/06/20	274.51KB	Share
AN1	Cellmid Reports on Strong QVC Sales Event	PRICE SENSITIVE	16/06/20	74.79KB	Share
AN1	Reinstatement to Official Quotation	PRICE SENSITIVE	15/06/20	86.79KB	Share
AN1	Cellmid Reports on Results of The Doherty Institute Testing	PRICE SENSITIVE	15/06/20	147.69KB	Share
AN1	CDY signs Introducer Agreement to broaden product offering	PRICE SENSITIVE	04/06/20	161.98KB	Share
AN1	Appointment of Dr Dominic Burg as Chief Operating Officer	PRICE SENSITIVE	01/06/20	65.5KB	Share
AN1	Results of Meeting		21/05/20	99.49KB	Share
AN1	General Meeting Presentation		21/05/20	1.93MB	Share
AN1	Company Update		15/05/20	83.31KB	Share
AN1	Update on General Meeting		14/05/20	1.78MB	Share
AN1	Suspension from Official Quotation	PRICE SENSITIVE	11/05/20	167.03KB	Share
AN1	Trading Halt	PRICE SENSITIVE	07/05/20	171.11KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	07/05/20	114.21KB	Share
AN1	Appendix 2A		04/05/20	270.52KB	Share
AN1	Cellmid Share Purchase Plan Completed		01/05/20	57.63KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	27/04/20	264.22KB	Share
AN1	Cellmid's Alopecia Patent Allowed in Australia and Japan	PRICE SENSITIVE	24/04/20	137.08KB	Share
AN1	Independent Test Results For The Wondfo SARS-CoV-2 Test	PRICE SENSITIVE	22/04/20	77.02KB	Share
AN1	Notice of General Meeting/Proxy Form		21/04/20	1.58MB	Share
AN1	Security Purchase Plan		17/04/20	212.38KB	Share
AN1	Cellmid's Shipment of SARS-CoV-2 Tests Received	PRICE SENSITIVE	14/04/20	61.63KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	14/04/20	114.6KB	Share
AN1	Appendix 2A and Cleansing Notice		14/04/20	338.67KB	Share
AN1	Proposed issue of Securities - CDY		08/04/20	26.83KB	Share
AN1	Reinstatement to Official Quotation	PRICE SENSITIVE	07/04/20	70.86KB	Share
AN1	Proposed issue of Securities - CDY		07/04/20	28.78KB	Share
AN1	Cellmid Share Placement Raises $6 Million	PRICE SENSITIVE	07/04/20	72.27KB	Share
AN1	Response to ASX Query Letter	PRICE SENSITIVE	06/04/20	662.92KB	Share
AN1	Suspension from Official Quotation	PRICE SENSITIVE	06/04/20	177.04KB	Share
AN1	Trading Halt	PRICE SENSITIVE	02/04/20	172.74KB	Share
AN1	Reinstatement to Official Quotation	PRICE SENSITIVE	27/03/20	71.03KB	Share
AN1	Market Update on COVID-19	PRICE SENSITIVE	27/03/20	69.7KB	Share
AN1	Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement	PRICE SENSITIVE	27/03/20	86.33KB	Share
AN1	Suspension from Official Quotation	PRICE SENSITIVE	24/03/20	178.81KB	Share
AN1	Trading Halt	PRICE SENSITIVE	20/03/20	173.63KB	Share
AN1	Appendix 3G		04/03/20	278.07KB	Share
AN1	Appendix 4D, Half Year Accounts and Presentation	PRICE SENSITIVE	26/02/20	3.06MB	Share
AN1	Cellmid's Evolis Patent to be Granted in China	PRICE SENSITIVE	04/02/20	70.43KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	30/01/20	236.85KB	Share
AN1	Key Midkine Antibody Patents Granted in the US and Europe	PRICE SENSITIVE	06/01/20	89.81KB	Share
AN1	Cellmid Reports on QVC Sales	PRICE SENSITIVE	05/12/19	93.27KB	Share
AN1	Change in substantial holding		22/11/19	863.77KB	Share
AN1	Change of Director's Interest Notice - Eck		22/11/19	259.43KB	Share
AN1	Change of Director's Interest Notice - Halasz		22/11/19	262.29KB	Share
AN1	Appendix 3B and Cleansing Notice		20/11/19	462.3KB	Share
AN1	Results of Annual General Meeting		19/11/19	97.95KB	Share
AN1	AGM Presentation to Shareholders		19/11/19	2.72MB	Share
AN1	Change of Director's Interest Notice - Cross		12/11/19	158.84KB	Share
AN1	Change of Director's Interest Notice - King		12/11/19	159.4KB	Share
AN1	Change of Director's Interest Notice - Gordon		12/11/19	158.5KB	Share
AN1	Appendix 3B and Cleansing Notice		08/11/19	470.68KB	Share
AN1	Cellmid Signs Trading Agreement With API/Priceline	PRICE SENSITIVE	06/11/19	95.47KB	Share
AN1	Cellmid Share Purchase Plan Completed		06/11/19	77.53KB	Share
AN1	Cellmid Appoints CEO to Advangen USA to Expand Distribution		31/10/19	82.69KB	Share
AN1	Supplementary Information on AGM Resolutions		24/10/19	88.59KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	23/10/19	248.37KB	Share
AN1	Notice of Annual General Meeting/Proxy Form		18/10/19	1.4MB	Share
AN1	Appendix 3B and Cleansing Notice		18/10/19	474.98KB	Share
AN1	SPP Offer Booklet		15/10/19	214.57KB	Share
AN1	Cleansing notice		15/10/19	78.94KB	Share
AN1	New TV Shopping Agreement for Evolis	PRICE SENSITIVE	14/10/19	89.05KB	Share
AN1	Cellmid Share Placement raises $1.5 million	PRICE SENSITIVE	14/10/19	72.41KB	Share
AN1	Trading Halt	PRICE SENSITIVE	10/10/19	130.36KB	Share
AN1	New Evolis Distribution & Supply Agreements - China & Europe	PRICE SENSITIVE	01/10/19	103.59KB	Share
AN1	Cellmid receives R&D tax credit		27/09/19	60.35KB	Share
AN1	Appendix 4G and Corporate Governance Statement		16/09/19	366.53KB	Share
AN1	Annual Report to shareholders		16/09/19	2.14MB	Share
AN1	FY19 Results Presentation		28/08/19	3.16MB	Share
AN1	FY2019 Financial Results	PRICE SENSITIVE	28/08/19	74.43KB	Share
AN1	Appendix 4E and FY19 Financial Report	PRICE SENSITIVE	28/08/19	2.1MB	Share
AN1	Patent for Improved Midkine Antibody Allowed in Europe	PRICE SENSITIVE	22/08/19	78.33KB	Share
AN1	CDY Signs Distribution Agreement for EVOLIS in South Korea	PRICE SENSITIVE	06/08/19	102.3KB	Share
AN1	Response to Appendix 4C Query	PRICE SENSITIVE	01/08/19	413.12KB	Share
AN1	Appendix 3B		30/07/19	383.94KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	26/07/19	279.33KB	Share
AN1	Cellmid Investor Newsletter		10/07/19	421.83KB	Share
AN1	Response to ASX Aware Query	PRICE SENSITIVE	08/07/19	434.23KB	Share
AN1	Cellmid Sets Another Sales Record in Q4 FY2019	PRICE SENSITIVE	04/07/19	93.84KB	Share
AN1	Change of Director's Interest Notice - Halasz		07/06/19	546.79KB	Share
AN1	FY2020 Growth Strategy Update		28/05/19	1.51MB	Share
AN1	Cellmid appoints new Lyramid CEO		28/05/19	207KB	Share
AN1	Minimum Holding Buy-Back Complete - ASIC Form 484		23/05/19	277.28KB	Share
AN1	Minimum Holding Buy-Back Closed		21/05/19	275.36KB	Share
AN1	Change of Director's Interest Notice - Maria Halasz		06/05/19	546.83KB	Share

AN1 CDY Engages Advisers to Facilitate Divestment from Lyramid
10/09/20		71.18KB	Share
AN1 FY20 Results Presentation
27/08/20		1.82MB	Share
AN1 FY20 Financial Results
27/08/20	PRICE SENSITIVE	73.95KB	Share
AN1 Appendix 4E and FY20 Financial Report
27/08/20	PRICE SENSITIVE	1.34MB	Share
AN1 CDY Signs Agreement With Premium Salon Distributor in USA
28/07/20	PRICE SENSITIVE	75.8KB	Share
AN1 Appendix 4C and Quarterly Activity Report
22/07/20	PRICE SENSITIVE	391.46KB	Share
AN1 Response to ASX Aware Query
09/07/20	PRICE SENSITIVE	218.16KB	Share
AN1 Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory
09/07/20	PRICE SENSITIVE	102.44KB	Share
AN1 Trading Halt
07/07/20	PRICE SENSITIVE	189.6KB	Share
AN1 Pause in Trading
07/07/20	PRICE SENSITIVE	113.64KB	Share
AN1 Extension Of Wondfo Rapid Test Distribution Agreement
02/07/20	PRICE SENSITIVE	84.81KB	Share
AN1 Change of Director's Interest Notice - Halasz
23/06/20		245.13KB	Share
AN1 Change in substantial holding
18/06/20		652.23KB	Share
AN1 Change of Director's Interest Notice - Eck
18/06/20		158.59KB	Share
AN1 Change of Director's Interest Notice - Halasz
18/06/20		207.02KB	Share
AN1 Appendix 3G
18/06/20		277.59KB	Share
AN1 Appendix 2A
18/06/20		274.51KB	Share
AN1 Cellmid Reports on Strong QVC Sales Event
16/06/20	PRICE SENSITIVE	74.79KB	Share
AN1 Reinstatement to Official Quotation
15/06/20	PRICE SENSITIVE	86.79KB	Share
AN1 Cellmid Reports on Results of The Doherty Institute Testing
15/06/20	PRICE SENSITIVE	147.69KB	Share
AN1 CDY signs Introducer Agreement to broaden product offering
04/06/20	PRICE SENSITIVE	161.98KB	Share
AN1 Appointment of Dr Dominic Burg as Chief Operating Officer
01/06/20	PRICE SENSITIVE	65.5KB	Share
AN1 Results of Meeting
21/05/20		99.49KB	Share
AN1 General Meeting Presentation
21/05/20		1.93MB	Share
AN1 Company Update
15/05/20		83.31KB	Share
AN1 Update on General Meeting
14/05/20		1.78MB	Share
AN1 Suspension from Official Quotation
11/05/20	PRICE SENSITIVE	167.03KB	Share
AN1 Trading Halt
07/05/20	PRICE SENSITIVE	171.11KB	Share
AN1 Pause in Trading
07/05/20	PRICE SENSITIVE	114.21KB	Share
AN1 Appendix 2A
04/05/20		270.52KB	Share
AN1 Cellmid Share Purchase Plan Completed
01/05/20		57.63KB	Share
AN1 Appendix 4C and Quarterly Activity Report
27/04/20	PRICE SENSITIVE	264.22KB	Share
AN1 Cellmid's Alopecia Patent Allowed in Australia and Japan
24/04/20	PRICE SENSITIVE	137.08KB	Share
AN1 Independent Test Results For The Wondfo SARS-CoV-2 Test
22/04/20	PRICE SENSITIVE	77.02KB	Share
AN1 Notice of General Meeting/Proxy Form
21/04/20		1.58MB	Share
AN1 Security Purchase Plan
17/04/20		212.38KB	Share
AN1 Cellmid's Shipment of SARS-CoV-2 Tests Received
14/04/20	PRICE SENSITIVE	61.63KB	Share
AN1 Pause in Trading
14/04/20	PRICE SENSITIVE	114.6KB	Share
AN1 Appendix 2A and Cleansing Notice
14/04/20		338.67KB	Share
AN1 Proposed issue of Securities - CDY
08/04/20		26.83KB	Share
AN1 Reinstatement to Official Quotation
07/04/20	PRICE SENSITIVE	70.86KB	Share
AN1 Proposed issue of Securities - CDY
07/04/20		28.78KB	Share
AN1 Cellmid Share Placement Raises $6 Million
07/04/20	PRICE SENSITIVE	72.27KB	Share
AN1 Response to ASX Query Letter
06/04/20	PRICE SENSITIVE	662.92KB	Share
AN1 Suspension from Official Quotation
06/04/20	PRICE SENSITIVE	177.04KB	Share
AN1 Trading Halt
02/04/20	PRICE SENSITIVE	172.74KB	Share
AN1 Reinstatement to Official Quotation
27/03/20	PRICE SENSITIVE	71.03KB	Share
AN1 Market Update on COVID-19
27/03/20	PRICE SENSITIVE	69.7KB	Share
AN1 Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
27/03/20	PRICE SENSITIVE	86.33KB	Share
AN1 Suspension from Official Quotation
24/03/20	PRICE SENSITIVE	178.81KB	Share
AN1 Trading Halt
20/03/20	PRICE SENSITIVE	173.63KB	Share
AN1 Appendix 3G
04/03/20		278.07KB	Share
AN1 Appendix 4D, Half Year Accounts and Presentation
26/02/20	PRICE SENSITIVE	3.06MB	Share
AN1 Cellmid's Evolis Patent to be Granted in China
04/02/20	PRICE SENSITIVE	70.43KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
30/01/20	PRICE SENSITIVE	236.85KB	Share
AN1 Key Midkine Antibody Patents Granted in the US and Europe
06/01/20	PRICE SENSITIVE	89.81KB	Share
AN1 Cellmid Reports on QVC Sales
05/12/19	PRICE SENSITIVE	93.27KB	Share
AN1 Change in substantial holding
22/11/19		863.77KB	Share
AN1 Change of Director's Interest Notice - Eck
22/11/19		259.43KB	Share
AN1 Change of Director's Interest Notice - Halasz
22/11/19		262.29KB	Share
AN1 Appendix 3B and Cleansing Notice
20/11/19		462.3KB	Share
AN1 Results of Annual General Meeting
19/11/19		97.95KB	Share
AN1 AGM Presentation to Shareholders
19/11/19		2.72MB	Share
AN1 Change of Director's Interest Notice - Cross
12/11/19		158.84KB	Share
AN1 Change of Director's Interest Notice - King
12/11/19		159.4KB	Share
AN1 Change of Director's Interest Notice - Gordon
12/11/19		158.5KB	Share
AN1 Appendix 3B and Cleansing Notice
08/11/19		470.68KB	Share
AN1 Cellmid Signs Trading Agreement With API/Priceline
06/11/19	PRICE SENSITIVE	95.47KB	Share
AN1 Cellmid Share Purchase Plan Completed
06/11/19		77.53KB	Share
AN1 Cellmid Appoints CEO to Advangen USA to Expand Distribution
31/10/19		82.69KB	Share
AN1 Supplementary Information on AGM Resolutions
24/10/19		88.59KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
23/10/19	PRICE SENSITIVE	248.37KB	Share
AN1 Notice of Annual General Meeting/Proxy Form
18/10/19		1.4MB	Share
AN1 Appendix 3B and Cleansing Notice
18/10/19		474.98KB	Share
AN1 SPP Offer Booklet
15/10/19		214.57KB	Share
AN1 Cleansing notice
15/10/19		78.94KB	Share
AN1 New TV Shopping Agreement for Evolis
14/10/19	PRICE SENSITIVE	89.05KB	Share
AN1 Cellmid Share Placement raises $1.5 million
14/10/19	PRICE SENSITIVE	72.41KB	Share
AN1 Trading Halt
10/10/19	PRICE SENSITIVE	130.36KB	Share
AN1 New Evolis Distribution & Supply Agreements - China & Europe
01/10/19	PRICE SENSITIVE	103.59KB	Share
AN1 Cellmid receives R&D tax credit
27/09/19		60.35KB	Share
AN1 Appendix 4G and Corporate Governance Statement
16/09/19		366.53KB	Share
AN1 Annual Report to shareholders
16/09/19		2.14MB	Share
AN1 FY19 Results Presentation
28/08/19		3.16MB	Share
AN1 FY2019 Financial Results
28/08/19	PRICE SENSITIVE	74.43KB	Share
AN1 Appendix 4E and FY19 Financial Report
28/08/19	PRICE SENSITIVE	2.1MB	Share
AN1 Patent for Improved Midkine Antibody Allowed in Europe
22/08/19	PRICE SENSITIVE	78.33KB	Share
AN1 CDY Signs Distribution Agreement for EVOLIS in South Korea
06/08/19	PRICE SENSITIVE	102.3KB	Share
AN1 Response to Appendix 4C Query
01/08/19	PRICE SENSITIVE	413.12KB	Share
AN1 Appendix 3B
30/07/19		383.94KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
26/07/19	PRICE SENSITIVE	279.33KB	Share
AN1 Cellmid Investor Newsletter
10/07/19		421.83KB	Share
AN1 Response to ASX Aware Query
08/07/19	PRICE SENSITIVE	434.23KB	Share
AN1 Cellmid Sets Another Sales Record in Q4 FY2019
04/07/19	PRICE SENSITIVE	93.84KB	Share
AN1 Change of Director's Interest Notice - Halasz
07/06/19		546.79KB	Share
AN1 FY2020 Growth Strategy Update
28/05/19		1.51MB	Share
AN1 Cellmid appoints new Lyramid CEO
28/05/19		207KB	Share
AN1 Minimum Holding Buy-Back Complete - ASIC Form 484
23/05/19		277.28KB	Share
AN1 Minimum Holding Buy-Back Closed
21/05/19		275.36KB	Share
AN1 Change of Director's Interest Notice - Maria Halasz
06/05/19		546.83KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $3.691M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
5	2513879	0.7¢

Sellers (Offers)

Price($)	Vol.	No.
0.8¢	226074	2

View Market Depth

No.	Vol.	Price($)
5	2513879	0.007
6	1429027	0.006
3	1000000	0.005
2	525000	0.004
1	600000	0.003

Price($)	Vol.	No.
0.008	226074	2
0.009	665742	3
0.010	385000	2
0.011	300000	1
0.012	83000	1

Last trade - 10.00am 29/05/2024 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

ANAGENICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories